EN | RU
EN | RU

Help Support

Back

High-flow nasal oxygen therapy improves survival rate in people with severe COVID-19 pneumonia

COVID-19 COVID-19
COVID-19 COVID-19

What's new?

The use of high-flow nasal oxygen therapy is linked with a reduced mortality rate in COVID-19 people with acute hypoxemic respiratory failure.

Compared to noninvasive ventilation, high-flow oxygen therapy (HFNO) substantially improved the survival rate in coronavirus-infected people with acute hypoxemic respiratory failure, according to the findings of a retrospective and comparative study published in “Annals of Medicine and Surgery”. Researchers aimed to compare the effectiveness of HFNO and noninvasive ventilation in 600 hospitalized people with severe COVID-19 pneumonia.

Out of 600 volunteers, 265 volunteers were incorporated in the assessment. A total of 162 (61.10%) volunteers were managed with HFNO. The intubation rate was 49.7% (80 volunteers out of 162). Out of this, 63 died intubated (78.8%). Notably, 19.8% of non-intubated volunteers died (16/82). A total of 71 volunteers received noninvasive ventilation (26.8%), 33 volunteers (46.5%) needed mechanical ventilation. The in-hospital mortality in noninvasive ventilation-treated volunteers was 100%.

No difference was noted in the intubation rate. In the HFNO group, the difference in mortality outcome between the two groups substantially dropped. Thus, in people with COVID-19 elicited acute respiratory failure, HFNO is a simple ventilatory support to use, better-tolerated and leads to significant improvement in survival rates in comparison with non-invasive ventilation.

Source:

Annals of Medicine and Surgery

Article:

High-flow nasal oxygen therapy decrease the risk of mortality and the use of invasive mechanical ventilation in patients with severe SARS-CoV-2 pneumonia? A retrospective and comparative study of 265 cases

Authors:

Rajae Alkouh et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies ru en
Try: